<DOC>
	<DOCNO>NCT00184002</DOCNO>
	<brief_summary>The current standard treatment non-Hodgkin 's lymphoma involve drug call cyclophosphamide , doxorubicin , vincristine , prednisone rituxan regimen call `` R-CHOP . '' Using R-CHOP therapy , complete disappearance disease expect 50 % people . One active drug R-CHOP regimen , doxorubicin , previously reformulate place fatty bubble call liposome . The reason place drug liposome evidence liposome well take tumor . This liposomally encapsulated form doxorubicin call Doxil show similar well anti-tumor certain tumor reduce side effect . Doxil FDA approve ovarian cancer . However use non-Hodgkin 's lymphoma still investigational . By substitute Doxil doxorubicin R-CHOP regimen , hop treatment well shrink tumor reduce side effect . The purpose study see well combination Doxil , rituximab , cyclophosphamide , vincristine prednisone ( DR-COP ) shrink tumor patient non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Doxorubicin ( Doxil ) Combined With Rituxan , Cyclophosphamide , Vincristine Prednisone Newly Diagnosed Aggressive Non-Hodgkin 's Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Pathologic diagnosis NonHodgkin 's lymphoma Bcell origin : follicular large cell , diffuse large cell ( include Bcell variant ) , Burkitt Burkittlike lymphoma All stage disease Measurable evaluable tumor parameter ( ) Age great 17 year old Karnofsky performance status great equal 50 % AGC great equal 1.0 ; platelet great equal 75,000 ( unless abnormal lymphoma ) Bilirubin le equal 2.0 ; SGOT le equal 3 time upper limit normal ( unless abnormal lymphoma ) Creatinine le equal 2.0 creatinine clearance great equal 60 ml/min ( unless abnormal lymphoma ) LVEF great equal 45 % Concurrent RT without steroid emergency condition secondary lymphoma ( i.e. , CNS tumor , cord compression ) permit Men woman childbearing potential must agree use adequate birth control duration therapy 3 month completion therapy Signed informed consent Prior systemic cytotoxic therapy RT lymphoma Second active tumor , nonmelanomatous skin ca insitu cervical cancer HIV seropositive Primary CNS lymphoma Pregnant nursing woman Unable comply requirement protocol , unable provide adequate inform consent , opinion PI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>